Key facts
- Arintra’s last known valuation is $44.3M (Aug 2025).
- It has raised $21.5M across 1 recorded rounds; the latest was Seed Round in Aug 2023.
- Notable investors include Y Combinator, Sequoia Capital, Google for Startups, Mana Ventures, Gaingels — 19 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Arintra
Funding rounds
1 roundsAbout Arintra
Developer of a medical coding platform designed to simplify patient intake and auto-generate documentation for a remote clinic. The company's platform offers to automate clinical workflows, generate accurate medical codes to improve billing for hospital systems, and significantly reduce administrative workload for healthcare practitioners, enabling the healthcare industry to improve patient experience and retention.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2019
- Employees
- 34
- Website
- arintra.com/
- Ownership
- Privately Held (backing)
Arintra doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arintra shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arintra in its N-PORT filings yet. We sweep new filings monthly.